Company profile
North Bud Farms Inc.
OTC: NOBDF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Toronto, ONReports USD
#1166 of 1,422 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 20
v0.1 · 5/100 weight · pillars only
↑ balance-sheet leverage, return on assets · ↓ disclosure history, Piotroski F
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$1.4M
Employees
—
as of 2026-07-12
Market cap
$634
as of 2026-07-12
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$00 CAD2018
Net income-$1.4M-1.8M CAD2018
Operating income-$1.4M-1.8M CAD2018
Total assets$5.8M7.7M CAD2018
Liabilities$758.0k1.0M CAD2018
Equity$5.0M6.7M CAD2018
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is North Bud Farms Inc.’s revenue?
North Bud Farms Inc. booked $0 in FY2018 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
TetraLogic Pharmaceuticals Corporation——BioELife Corp.——Rapid Therapeutic Science Laboratories, Inc.——OncoSec Medical Incorporated——Cannabiz Mobile, Inc.——Verde Science, Inc.——Key facts
CEORyan Brown
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersToronto, ON
ExchangeOTC: NOBDF
Employees—
IPO date2018-11-01
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.